Capricor Therapeutics Stock Price, News & Analysis
CAPR
NASDAQ
Company Description
Welcome to the overview page for Capricor Therapeutics (CAPR), where you can find comprehensive stock information and company updates.
Explore the latest news on strategic partnerships, quarterly and annual financial results, and regulatory filings including SEC reports and insider transactions.
Visualize performance trends using the interactive price chart, and keep track of upcoming events such as earnings calls, dividend dates, and investor conferences.
Stock Performance
Latest News
SEC Filings
Financial Highlights
$22,270,465
Revenue (TTM)
-$40,467,186
Net Income (TTM)
-$1.15
-$39,995,742
Operating Cash Flow
-181.71%
-191.13%
Upcoming Events
JAN
01
January 1, 2026 - March 31, 2026
Clinical
Initial trial data release
Initial Phase 1 StealthX trial data; NIAID-funded, four dosing arms
JAN
01
January 1, 2026 - March 31, 2026
Clinical
StealthX Phase 1 data
NIAID-sponsored StealthX Phase 1 topline data release period
JAN
07
January 7, 2026
Financial
Underwriters' option expiry
30-day option for up to 900,000 additional shares at offering price; exercisable by underwriters
Short Interest History
Last 12 Months
Loading short interest data...
Days to Cover History
Last 12 Months
Loading days to cover data...
Frequently Asked Questions
What is the current stock price of Capricor Therapeutics (CAPR)?
The current stock price of Capricor Therapeutics (CAPR) is $28.86 as of December 31, 2025.
What is the market cap of Capricor Therapeutics (CAPR)?
The market cap of Capricor Therapeutics (CAPR) is approximately 1.6B. Learn more about what market capitalization means .
What is the revenue (TTM) of Capricor Therapeutics (CAPR) stock?
The trailing twelve months (TTM) revenue of Capricor Therapeutics (CAPR) is $22,270,465.
What is the net income of Capricor Therapeutics (CAPR)?
The trailing twelve months (TTM) net income of Capricor Therapeutics (CAPR) is -$40,467,186.
What is the earnings per share (EPS) of Capricor Therapeutics (CAPR)?
The diluted earnings per share (EPS) of Capricor Therapeutics (CAPR) is -$1.15 on a trailing twelve months (TTM) basis. Learn more about EPS .
What is the operating cash flow of Capricor Therapeutics (CAPR)?
The operating cash flow of Capricor Therapeutics (CAPR) is -$39,995,742. Learn about cash flow.
What is the profit margin of Capricor Therapeutics (CAPR)?
The net profit margin of Capricor Therapeutics (CAPR) is -181.71%. Learn about profit margins.
What is the operating margin of Capricor Therapeutics (CAPR)?
The operating profit margin of Capricor Therapeutics (CAPR) is -191.13%. Learn about operating margins.
What is the current ratio of Capricor Therapeutics (CAPR)?
The current ratio of Capricor Therapeutics (CAPR) is 7.77, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.
What is the operating income of Capricor Therapeutics (CAPR)?
The operating income of Capricor Therapeutics (CAPR) is -$42,564,842. Learn about operating income.